An interventional study of Theory-Based Structured Educational Program and Usual Care in Ventilator-Associated Pneumonia Prevention and Intensive Care Nursing Care, sponsored by JAWAD AHMAD ABU-SHENNAR. Completed at 1 site in Jordan. Per ClinicalTrials.gov, last updated 2026-09-15.
Sponsored by JAWAD AHMAD ABU-SHENNAR · Not applicable, Interventional, and Prevention
Ventilator-associated pneumonia (VAP) is an important challenge in intensive care and requires nurses to apply evidence-based preventive practices consistently in mechanically ventilated patients. This multicenter cluster-randomized controlled trial evaluates the effectiveness of a theory-based structured educational program designed to improve VAP prevention knowledge, reflective nursing practice related to invasive mechanical ventilation, quality of nursing care, and family satisfaction with intensive care unit (ICU) care. The program integrates evidence-based VAP prevention education with clinical decision-making, case-based learning, simulation, reflective exercises, structured debriefing, and practice-improvement planning. Adult ICU nurses working in Ministry of Health hospitals in Jordan are assigned by ICU cluster to either the educational intervention or usual care. Outcomes are assessed at baseline, immediately after the intervention, and six months after completion to evaluate immediate effects and sustainability. VAP prevention knowledge is the primary outcome, while reflective nursing practice, quality of nursing care, and family satisfaction with ICU care are secondary outcomes.
This study is a national, multicenter, two-arm, parallel-group cluster-randomized controlled trial evaluating a theory-based structured educational program for nurses working in adult intensive care units (ICUs) affiliated with the Ministry of Health in Jordan. Cluster randomization is conducted at the ICU level to reduce contamination among nurses working within the same clinical environment.
The educational program is theoretically grounded in Schön's Reflective Practice Theory and was developed to support the integration of evidence-based VAP prevention knowledge with clinical reasoning and reflective nursing practice. The program consists of four weekly educational sessions, each lasting approximately three hours, for a total of approximately 12 contact hours. Educational strategies include interactive lectures, case-based learning, group discussion, clinical scenarios, demonstration, simulation-based learning, reflective exercises, structured debriefing, and practice-improvement planning.
The first session focuses on VAP prevention knowledge and clinical decision-making, including VAP risk factors, mechanisms contributing to VAP development, evidence-based preventive practices, oral care, positioning, airway and secretion management, aspiration prevention, hand hygiene, and relevant ventilator-care bundle components. The second session addresses nursing care of mechanically ventilated patients and the integration of reflective practice into routine ICU care. The third session uses simulation-based clinical scenarios involving mechanically ventilated patients and is followed by structured reflective debriefing. The fourth session integrates the major concepts, addresses barriers to implementation, and supports the development of individualized practice-improvement plans.
Participants in the control group receive usual institutional care and education. Routine institutional education and patient-safety procedures are not withheld. The study-specific structured educational program is not provided to control ICUs during the active intervention period.
Study outcomes are assessed at three prespecified time points: baseline (T0), immediately after completion of the educational program (T1), and six months after intervention completion (T2). The primary outcome is VAP prevention knowledge. Secondary nurse-level outcomes include reflective nursing practice related to invasive mechanical ventilation and quality of nursing care. Family satisfaction with ICU care is evaluated as a family-level secondary outcome using the FS-ICU 24R. Family respondents are recruited independently of participating nurses and are linked to the relevant ICU and assessment period rather than to individual nurses.
The primary treatment effect is evaluated by examining the difference in change between intervention and control groups over time, with particular emphasis on the group-by-time interaction from baseline to the immediate post-intervention assessment. The six-month assessment evaluates retention and sustainability of intervention effects. Longitudinal analyses account for the clustered nature of the trial and repeated measurements.
The study was conducted among attending nurses working in intensive care units affiliated with the Ministry of Health (MOH), Jordan, during the period from August 2025 to February 2026.
420 studies on the registry are indexed under Pneumonia, Ventilator-Associated; 85 are open to participants now.
This study's enrollment of 600 is above the median of 115 across 276 interventional studies indexed under Pneumonia, Ventilator-Associated.
Browse Pneumonia, Ventilator-Associated studies →JAWAD AHMAD ABU-SHENNAR is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Willingness to participate voluntarily and provide written .
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in ICUs assigned to the intervention group receive a theory-based structured educational program designed to improve VAP prevention knowledge, reflective nursing practice related to invasive mechanical ventilation, and quality of nursing care. The program consists of four weekly sessions of approximately three hours each and incorporates interactive education, case-based learning, clinical scenarios, simulation, reflective exercises, structured debriefing, and practice-improvement planning.
Behavioral: Theory-Based Structured Educational Program
Participants in ICUs assigned to the control group receive usual institutional care and education. Routine institutional education, clinical policies, and patient-safety procedures are not withheld. The study-specific structured educational program is not provided to control ICUs during the active intervention period.
Behavioral: Usual Care
A standardized, theory-based structured educational program developed for ICU nurses and grounded in Schön's Reflective Practice Theory. The program consists of four weekly sessions, each lasting approximately three hours, for approximately 12 total contact hours. The sessions integrate evidence-based VAP prevention education, clinical decision-making, invasive mechanical ventilation nursing care, case-based learning, simulation-based learning, reflective exercises, structured debriefing, and practice-improvement planning. The intervention is designed to support the application of VAP prevention knowledge through clinical reasoning and reflective nursing practice.
Usual institutional care and education provided to ICU nurses according to routine hospital policies and clinical practices. Routine institutional education, patient-safety procedures, and standard clinical care are not withheld. The study-specific theory-based structured educational program is not provided to control ICUs during the active intervention period.
VAP Prevention Knowledge
VAP prevention knowledge among ICU nurses, assessed using the validated VAP knowledge questionnaire developed by Labeau et al. Higher scores indicate greater knowledge regarding VAP prevention.
Time frame: Baseline (T0) to immediately post-intervention (T1), with a six-month follow-up assessment (T2) to evaluate retention and sustainability.
Reflective Nursing Practice Related to Invasive Mechanical Ventilation
Reflective nursing practice related to invasive mechanical ventilation, assessed using the Questionnaire for Reflective Practice of Nursing Involving Invasive Mechanical Ventilation (Q-RPN-IMV). Higher scores indicate a greater level of reflective nursing practice.
Time frame: Baseline (T0), immediately post-intervention (T1), and six months after intervention completion (T2).
Quality of Nursing Care in the Intensive Care Unit
Quality of nursing care in the ICU, assessed using the Quality of Nursing Care Scale-ICU. Higher scores indicate better quality of nursing care according to the instrument's established scoring framework.
Time frame: Baseline (T0), immediately post-intervention (T1), and six months after intervention completion (T2).
Family Satisfaction with ICU Care
Family satisfaction with ICU care, assessed at the family level using the Family Satisfaction in the ICU (FS-ICU 24R). The outcome reflects family members' satisfaction with ICU care, including satisfaction with care and decision-making and communication.
Time frame: Baseline (T0), immediately post-intervention (T1), and six months after intervention completion (T2).
Plan to share: No
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pneumonia, Ventilator-Associated →